ADAMTS-1在大鼠肺纤维化组织中的表达及苦参素的干预作用
[Abstract]:Objective: To study the dynamic changes of the expression of the depolymerized substance-like matrix metalloprotease (ADAMTS-1) containing the type I platelet-binding protein motif in the rat pulmonary fibrosis and the effect of the intervention, and to clarify the molecular mechanism of ADAMTS-1 in the pulmonary fibrosis and the mechanism of the anti-pulmonary fibrosis. Methods:60 SD rats were randomly divided into 4 groups: control group, model group, low dose (50 mg/ kg) and high dose (100 mg/ kg). The lung tissue ADAMTS-1, type I collagen (COLI) and mRNA were measured by immunohistochemistry and RT-PCR. Flat. Results:1, HE staining, Mass On-on triple-staining HE staining: the alveolar structure of the control group was normal and clear, and the alveolar space was not found. Abnormal collagen deposition. The rats in the model group of the pulmonary fibrosis showed a clear acute inflammation phase on the 7th day, with a large number of inflammatory cells infiltrates; at 14 days, the lung interval was significantly increased, the collagen deposition increased and the fibrosis of the plaque was changed; a large amount of the sheet-like collagen fiber was visible on the 28-day period, The structural disorder of the lung tissue, the infiltration and the stabilization of a few inflammatory cells The formation of pulmonary fibrosis. Masson staining: The collagen fibers present a large amount of blue-green,14-day, and 28-day The aggregation and deposition of collagen fibers in the control group, the bronchial wall and the interstitial part of the lung in the control group Compared with the model group, there was a significant reduction in the aggregation and deposition of the collagen fibers in the low-dose and low-dose elements of the intervention group and the model group, compared with the model group. The distribution and quantity of the fiber are slightly less .2. The higher the content of HYP in the model group, the higher the content of HYP in the model group, the higher the content of HYP in the model group than that of the control group (P0.05). No significant difference (P> 0.05), compared with the high-dose element group. The difference was significant (P 0.05).3. ADA The expression of MTS-1 protein in the pulmonary fibrosis of ADAMTS-1 was expressed in all the time points of the model group, and the expression of MTS-1 protein gradually decreased with the increasing of time. 4-day,28-day expression, over time The expression of ADAMTS-1 in the model group was significantly lower than that of the control group (P0.05). The expression of ADAMTS-1 in the latter group was significantly higher and the difference was significant (P 0.05). Compared with the group, the difference was significant (P 0.05).4. RT-PCR detection of pulmonary fibrosis The expression of ADAMTS-1 and COLI mRNA was the highest in the control group, and the expression level of ADAMTS-1 mRNA in the model group was significantly lower than that in the control group (P0.05). Compared with the control group (P 0.05), there was no significant difference between the low dose and the model group (P 0.05). The expression of COLI mRNA in the model group at 7,14 and 28 days was significant (P0.05). (a) (a) (a The highest expression was found at 28 days in model group (P0.05). 1. ADAMTS-1 in the lung tissue of rats with pulmonary fibrosis Up to down.2. The expression of COLI in lung tissue of rats with pulmonary fibrosis was increased.
【学位授予单位】:南华大学
【学位级别】:硕士
【学位授予年份】:2012
【分类号】:R285.5;R563.9
【参考文献】
相关期刊论文 前10条
1 刘承云;血清Ⅰ、Ⅲ型前胶原端肽浓度在心血管疾病中的意义[J];国外医学.心血管疾病分册;1997年04期
2 郝小惠,张丽,王献华;胶原与肺间质纤维化的研究进展[J];华北煤炭医学院学报;2005年01期
3 李磊,金玉,张宏文;苦参碱抑制大鼠肾间质纤维化的实验研究[J];四川中医;2005年02期
4 厉启芳;;苦参碱干预特发性肺纤维化临床研究[J];山东中医药大学学报;2011年01期
5 王利;王宪;孔炜;;新型金属蛋白酶ADAMTS家族的研究进展[J];生理科学进展;2008年01期
6 贾鹏;张平;;基因芯片技术在肺纤维化致病基因的研究现状和进展[J];社区医学杂志;2010年01期
7 蒋之;万珂;肖霞;;苦参碱对肺纤维化大鼠肺组织HYP与HGF表达的影响[J];实用预防医学;2011年06期
8 宋慧文;;苦参素对兔实验性左房纤维化的影响[J];实用医学杂志;2009年11期
9 姚钢炼;宁宁;高登峰;桂保松;;氧化苦参碱在大鼠肾间质纤维化进程中的保护作用[J];西安交通大学学报(医学版);2006年03期
10 康文臻;谢玉梅;聂青和;张岩;郝春秋;王久平;陈伟红;;苦参素对实验性大鼠肝纤维化防治作用的研究[J];世界华人消化杂志;2003年02期
相关博士学位论文 前3条
1 张召才;病毒性心脏病心肌纤维化的发生机制及其药物干预研究[D];复旦大学;2004年
2 申锷;CVB_3致小鼠病毒性心脏病心肌纤维化的发生机制及其药物治疗研究[D];复旦大学;2007年
3 郭春艳;慢性病毒性心肌炎胶原代谢变化及苦参素与卡托普利抗心肌纤维化作用比较研究[D];山东大学;2010年
相关硕士学位论文 前1条
1 王在岩;白藜芦醇对博莱霉素致大鼠肺纤维化及其HIF-1α和NF-κB表达的影响[D];南华大学;2011年
本文编号:2442384
本文链接:https://www.wllwen.com/yixuelunwen/huxijib/2442384.html